middle.news
How Memphasys Is Driving Felix™ Commercialisation with Global Regulatory Wins
11:14am on Friday 27th of February, 2026 AEDT
•
Healthcare
Read Story
How Memphasys Is Driving Felix™ Commercialisation with Global Regulatory Wins
11:14am on Friday 27th of February, 2026 AEDT
Key Points
Regulatory approvals secured in UK, EU, and Australia
Five-year European supply deal with Italian fertility group
Initial orders and expanding sales in MENA and India
Operating costs cut by 39% through restructuring
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
MEMPHASYS (ASX:MEM)
OPEN ARTICLE